Tempus AI (NASDAQ:TEM) Price Target Cut to $89.00 by Analysts at HC Wainwright

Tempus AI (NASDAQ:TEM) had its price target cut by HC Wainwright from $98.00 to $89.00 in a research report released on Friday,Benzinga reports. They currently have a buy rating on the stock.

Several other equities research analysts also recently weighed in on the stock. Needham & Company LLC increased their target price on shares of Tempus AI from $70.00 to $100.00 and gave the stock a “buy” rating in a research note on Wednesday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. Canaccord Genuity Group decreased their price objective on Tempus AI from $110.00 to $95.00 and set a “buy” rating for the company in a research report on Wednesday. Cowen lowered Tempus AI from a “buy” rating to a “hold” rating in a report on Tuesday, October 21st. Finally, Guggenheim upped their price target on Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 26th. Seven analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $79.85.

Tempus AI Stock Performance

Shares of TEM traded down $0.53 during mid-day trading on Friday, reaching $71.56. 8,930,044 shares of the company’s stock were exchanged, compared to its average volume of 6,851,390. The business’s fifty day simple moving average is $85.91 and its 200-day simple moving average is $70.82. The stock has a market capitalization of $12.43 billion, a PE ratio of -60.13 and a beta of 4.86. Tempus AI has a 52-week low of $31.36 and a 52-week high of $104.32. The company has a debt-to-equity ratio of 2.45, a current ratio of 3.28 and a quick ratio of 1.43.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.05. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The firm had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. During the same quarter in the prior year, the firm earned ($0.46) EPS. Tempus AI’s revenue for the quarter was up 84.7% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. On average, equities research analysts expect that Tempus AI will post -6.15 earnings per share for the current year.

Insider Transactions at Tempus AI

In other Tempus AI news, CAO Ryan M. Bartolucci sold 1,904 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $142,133.60. Following the completion of the sale, the chief accounting officer owned 45,895 shares of the company’s stock, valued at approximately $3,426,061.75. This trade represents a 3.98% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director David R. Epstein sold 370 shares of the business’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $90.00, for a total transaction of $33,300.00. Following the sale, the director owned 26,671 shares in the company, valued at $2,400,390. The trade was a 1.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 1,105,282 shares of company stock valued at $87,726,381. 26.27% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in TEM. GSA Capital Partners LLP acquired a new stake in Tempus AI in the 3rd quarter valued at about $604,000. Vanguard Group Inc. grew its position in shares of Tempus AI by 22.1% in the third quarter. Vanguard Group Inc. now owns 9,441,607 shares of the company’s stock valued at $762,032,000 after purchasing an additional 1,706,837 shares during the last quarter. State of New Jersey Common Pension Fund D grew its position in shares of Tempus AI by 4.2% in the third quarter. State of New Jersey Common Pension Fund D now owns 33,111 shares of the company’s stock valued at $2,672,000 after purchasing an additional 1,323 shares during the last quarter. PNC Financial Services Group Inc. increased its stake in shares of Tempus AI by 16.2% during the 3rd quarter. PNC Financial Services Group Inc. now owns 5,815 shares of the company’s stock worth $469,000 after purchasing an additional 812 shares in the last quarter. Finally, Ameritas Advisory Services LLC acquired a new position in shares of Tempus AI during the 3rd quarter worth approximately $843,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.